Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Regains Compliance With Nasdaq Listing Requirements

NEW YORK (GenomeWeb) – WaferGen Bio-systems announced that its shares have regained compliance for listing on the Nasdaq.

On Dec. 13, the Fremont, California-based firm received a letter from the market's Listing Qualifications Department acknowledging that the closing bid price of its common stock had been $1.00 or more for ten consecutive business days as of Dec. 12.

This follows a 1-for-5 reverse stock split the company effected on Nov. 28 in a bid to boost the shares and satisfy the minimum bid price requirement for continued listing. The firm is set to merge with Takara Bio USA in a deal that will be based on consolidated fiscal year 2016 revenues, rather than share price.

In morning trading on the Nasdaq, shares of WaferGen were up almost 2 percent to $4.88.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.